Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 13;10(6):940.
doi: 10.3390/vaccines10060940.

Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods

Affiliations

Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods

Le Duc Huy et al. Vaccines (Basel). .

Abstract

Our study aims to compare the pandemic resilience index and explore the associated factors during the Delta and Omicron variant periods. In addition, the study aims to identify the characteristics of countries that had good performances. We analyzed observation data among 29 countries over the first eight weeks during the two periods of Delta and Omicron variant dominance. Data were extracted from open public databases. The Omicron variant caused a lowered mortality rate per 100,000 COVID-19 patients; however, it is still imposing a colossal burden on health care systems. We found the percentage of the population fully vaccinated and high government indices were significantly associated with a better resilience index in both the Delta and Omicron periods. In contrast, the higher death rate of cancers and greater years lived with disability (YLD) caused by low bone density were linked with poor resilience index in the Omicron periods. Over two periods of Delta and Omicron, countries with good performance had a lower death rate from chronic diseases and lower YLD caused by nutrition deficiency and PM2.5. Our findings suggest that governments need to keep enhancing the vaccine coverage rates, developing interventions for populations with chronic diseases and nutrition deficiency to mitigate COVID-19 impacts on these targeted vulnerable cohorts.

Keywords: COVID-19; Delta; NPIs; Omicron; vaccine; variants.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Time lag effects of vaccination and NPIs during study periods.
Figure 2
Figure 2
Government response and vaccination coverage across 29 countries over the first 8 weeks of the Delta and Omicron variant periods. Country Abbreviations: AUS—Australia, BEL—Belgium, BGR—Bulgaria, CAN—Canada, CZE—Czechia, CHE—Switzerland, DNK—Denmark, ESP—Spain, EST—Estonia, FIN—Finland, FRA—France, GBR—United Kingdom, IRL—Ireland, ISR—Israel, ITA—Italy, JPN—Japan, LUX—Luxembourg, LVA—Latvia, MLT—Malta, MYS—Malaysia, NLD—Netherlands, PRT—Portugal, ROU—Romania, SGP—Singapore, SRB—Serbia, SVK—Slovakia, SVN—Slovenia, SWE—Sweden, USA—United States.
Figure 3
Figure 3
COVID-19 infection characteristics between the Delta and Omicron variant periods.
Figure 4
Figure 4
The evolution of the resilience index across 29 countries over the first 8 weeks during the Delta and Omicron variant periods. Country Abbreviations: AUS—Australia, BEL—Belgium, BGR—Bulgaria, CAN—Canada, CZE—Czechia, CHE—Switzerland, DNK—Denmark, ESP—Spain, EST—Estonia, FIN—Finland, FRA—France, GBR—United Kingdom, IRL—Ireland, ISR—Israel, ITA—Italy, JPN—Japan, LUX—Luxembourg, LVA—Latvia, MLT—Malta, MYS—Malaysia, NLD—Netherlands, PRT—Portugal, ROU—Romania, SGP—Singapore, SRB—Serbia, SVK—Slovakia, SVN—Slovenia, SWE—Sweden, USA—United States.
Figure 5
Figure 5
Multivariate linear mixed effect models of factors associated with the resilience index.

Similar articles

Cited by

References

    1. Patel M.D., Rosenstrom E., Ivy J.S., Mayorga M.E., Keskinocak P., Boyce R.M., Hassmiller Lich K., Smith R.L., III, Johnson K.T., Delamater P.L., et al. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions with Infections, Hospitalizations, and Mortality. JAMA Netw. Open. 2021;4:e2110782. doi: 10.1001/jamanetworkopen.2021.10782. - DOI - PMC - PubMed
    1. Johns Hopkins Coronavirus Resource Center Pandemic Data Initiative. [(accessed on 19 May 2021)]. Available online: https://coronavirus.jhu.edu/pandemic-data-initiative.
    1. Lin T.-Y., Liao S.-H., Lai C.-C., Paci E., Chuang S.-Y. Effectiveness of Non-Pharmaceutical Interventions and Vaccine for Containing the Spread of COVID-19: Three Illustrations before and after Vaccination Periods. J. Formos. Med. Assoc. 2021;120((Suppl. 1)):S46–S56. doi: 10.1016/j.jfma.2021.05.015. - DOI - PMC - PubMed
    1. Jecker N.S., Au D.K.S. Does Zero-COVID Neglect Health Disparities? J. Med. Ethics. 2022;48:169–172. doi: 10.1136/medethics-2021-107763. - DOI - PubMed
    1. Dyer O. COVID-19: Omicron Is Causing More Infections but Fewer Hospital Admissions than Delta, South African Data Show. BMJ. 2021;375:n3104. doi: 10.1136/bmj.n3104. - DOI - PubMed

LinkOut - more resources